For More Information
Interested in learning about how Linical Americas can impact your next study?Learn More
Join Our investigator Network
Interested in becoming part of the Linical Americas Investigator network?Learn More
Linical's commitment to providing quality services starts with our people. Our team members are passionate about their work and are dedicated to fulfilling each client's requirements in a timely, accurate, well managed and cost-effective manner.
Our executive management team combines entrepreneurial business talents, clinical and medical expertise, and biotech industry experience to effectively lead the vision of the company. The following individuals are the foundation of Linical's ability to the address clinical needs and business objectives of those we serve.
Ms. Lanoce leads the Linical Americas organization. Ms. Lanoce ensures operational excellence is achieved by applying high industry standards, policies, systems and processes across the organization. In addition to leading the organization, Ms. Lanoce oversees the organization’s Clinical Operations and Biometrics division, including Data Management and Biostatistics. Ms. Lanoce has more than 22 years of experience in the clinical research industry. Prior to joining Linical, Ms. Lanoce had a 15 year tenure with Radiant Development where she held positions of increasing responsibility including Site Director, Director Regional Operations, Director Operations, and Vice President Clinical Operations. Prior to joining Radiant Development, Ms. Lanoce was the Managing Partner and Director of Clinical Operations for two clinical research facilities located in Stuart and Lake Worth, Florida. Ms. Lanoce has held a variety of positions in the biopharmaceutical industry including Clinical Scientist at Bristol-Meyers Squibb and Regional Manager for Covance. Ms. Lanoce holds a Master's of Science in Biomedical Engineering from Rutgers University and a Bachelor of Arts in Biology from Manhattanville College.
As Chief Medical Officer of Linical Americas, Dr. Goeken is responsible for providing strategic and operational leadership regarding the Company’s Medical and Scientific Operations. Dr. Goeken oversees clinical development functions and activities within the company including Medical, Regulatory, Medical Writing and Pre and Post Market Pharmacovigilance departments ensuring global alignment and operational excellence. Dr. Goeken received his M.D. from St. Christopher’s College of Medicine in the UK, having completed his clinical training at LSU Health Sciences Center in Louisiana and Sub-Internship in High Risk Maternal Fetal Medicine at Ochsner Clinic Foundation in Louisiana. Prior to joining Linical, Dr. Goeken held positions at The Methodist Hospital Research Institute in Houston, Texas, Pharm-Olam International, Nuron Biotech and Somahlution. Dr. Goeken has substantial global experience with clinical development and medical affairs functions leading global product development efforts from first in man/proof of concept through pivotal study, product launch and beyond. He is experienced with multiple therapeutic indications across drug/biologic and medical device platforms.
As Chief Operating Officer, Ms. McHugh is responsible for the Clinical Operations and Biometrics departments of Linical Americas. Ms. McHugh's professional experience spans over 20 years in clinical trials and information technology. Her career began designing and developing software for the government and commercial healthcare sectors. Ms. McHugh was promoted into various IT management roles before taking on operational management and business development roles in the Site Management Organization (SMO) space, including COO and then CEO of Radiant Research. After facilitating the sale of Radiant in 2012, Ms. McHugh joined Linical (formerly Accelovance) as Vice President of Clinical Operations. She left Accelovance in 2015 to consult to various companies in the areas of strategic planning, operational management, project management, clinical monitoring, system implementation and validation, and compliance. Ms. McHugh rejoined Linical in 2019. Ms. McHugh graduated Magna Cum Laude with a Bachelor of Arts in Mathematics from the University of Dayton.
Dr. Michelle Thompson provides strategic direction for Linical Americas in the areas of business growth, business development and new partnership alignment. She has more than 25 years of experience in the pharmaceutical and CRO industry, leading and building global sales organizations, driving acquisition and change activity, and managing subsequent adjustments in corporate branding and messaging. Prior to joining Linical, Dr. Thompson held various sales management positions at PRA Health Sciences, culminating in Vice President of Global Business Development. She was the Vice President of Global Business Development and Marketing at Focus Bio-Inova, a central and specialty microbiology laboratory, and led the development of the global alliance management function across the laboratories at Pharmaceutical Products Development (bioanalytical, biomarkers, vaccine development and central labs). Additionally, she was an independent consultant for eight years, working with biotech, large pharmaceutical companies, venture capital firms and healthcare organizations. Before moving into her sales and marketing career, Dr. Thompson was a clinical scientist at Bristol Myers Squibb, and a study coordinator at the University of Connecticut. Academically, Dr. Thompson was a tenure-track assistant professor of marketing at the Helzberg School of Management at Rockhurst University in Kansas City, and an adjunct professor of psychology at the University of Connecticut. She holds a PhD and Post-Doctoral Fellowship in Neuroscience from the University of Connecticut as well as an MBA from the University of North Carolina.
Dr. Wendy (Wen-Ying) Wang is the Managing Director at Linical Accelovance China. As Head of Linical Accelovance China, Dr. Wang helps western pharmaceutical companies with global clinical trial registration, import drug registration, regulatory consultancy, clinical site management, and project management of multi-center global clinical trials in China. Dr. Wang has broad experiences in research, technical, sales, quality, medical and regulatory affairs within the biotechnology and pharmaceutical industries in the areas of bioactive enzymes, medicines, and vaccines in Greater China and Asia Pacific regions. Dr. Wang earned her clinical medicine degree from Shandong Weifang Medical College, Master's degree in gastroenterological physiology from Peking Union Medical College, and her PhD in the regulation of angiogenesis by vascular endothelial growth factor from the University of Bristol in the United Kingdom.
Cathy Gooch, MBA, is the Vice President of Talent and Resource Management. She is responsible for providing leadership in the areas of human resources, talent acquisition, talent management and utilization. Mrs. Gooch has 30 years’ experience as a human resources and recruitment professional and 18 years’ in the life sciences sector. Prior to joining Linical, Mrs. Gooch was with Chiltern for ten years where she earned roles of progressively greater scope, complexity and responsibility in Human Resources, Resourcing Solutions and Global Talent Acquisition. She also worked with Worldwide Clinical Trials, and she began her career in clinical research while working with Kelly Services and Kelly Scientific. Mrs. Gooch holds a MBA in Human Resources Management from Columbia Southern University and a BA in Human Resources from Georgia State University.
Dr. Dave is the Global Oncology Therapeutic Lead for Linical Americas. Dr. Dave has 25+ years of Phase I-IV clinical research experience including the conduct of over a 100 studies with a focus on hematology, oncology and transplantation as well as other areas of internal medicine. Dr. Dave provides integrated drug development and therapeutic advice, management of clinical trials, and expertise and due diligence for biotech, small, medium and large pharma and VC companies. He has scientific expertise in gene regulation, gene therapy and tumor immunology; clinical and academic expertise in hematology including coagulation disorders, oncology and transplantation; and industry experience in hematology/oncology drug development from pre-clinical to phase IV space and in biosimilars/biobetters and immunotherapeutics. Prior to joining Accelovance, Dr. Dave held positions at Quintiles, George Washington University Medical Center and VA Medical Center in Washington, DC and NIH in Bethesda, MD. Dr. Dave holds a MB, ChB from the University of Sheffield and a MBA from the TRIUM program (jointly awarded by NYU, London School of Economics and HEC).